NextCure, Inc.
NXTC
$5.22
$0.0851.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.93M | -49.52M | -55.65M | -58.52M | -61.28M |
| Total Depreciation and Amortization | 2.66M | 2.73M | 2.87M | 3.02M | 3.26M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.56M | 5.39M | 7.45M | 7.88M | 8.38M |
| Change in Net Operating Assets | -426.00K | 207.00K | 4.53M | 3.11M | 3.81M |
| Cash from Operations | -54.13M | -41.19M | -40.81M | -44.51M | -45.83M |
| Capital Expenditure | -136.00K | -437.00K | -474.00K | -521.00K | -630.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.25M | 44.96M | 55.78M | 53.03M | 45.11M |
| Cash from Investing | 36.12M | 44.52M | 55.31M | 52.51M | 44.48M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.06M | 143.00K | 144.00K | 179.00K | 178.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.06M | 143.00K | 144.00K | 179.00K | 178.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.96M | 3.47M | 14.65M | 8.18M | -1.17M |